Ozlem Oyardi
Overview
Explore the profile of Ozlem Oyardi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozturk O, Oyardi O, Dundar Y
Bioorg Chem
. 2024 Dec;
154:108079.
PMID: 39729766
Bacillus cereus sphingomyelinase C (B. cereus SMase), which plays a crucial role in bacterial virulence, has emerged as a new therapeutic target for treating opportunistic infections caused by this pathogen....
2.
Oyardi O, Hacioglu M, Ozdemir E, Erbay M, Kultur S, Bozkurt Guzel C
Turk J Pharm Sci
. 2024 Jul;
21(3):252-258.
PMID: 38994879
Objectives: Plant extracts are important natural resources that may have antimicrobial and antibiofilm effects against pathogens. This study was conducted to investigate the in vitro antimicrobial activities of methanol extracts...
3.
Oyardi O, Nur Yilmaz F, Dosler S
Curr Microbiol
. 2024 Jun;
81(8):241.
PMID: 38910195
Zoliflodacin is a spiropyrimidinetrione antibiotic that acts by binding to the GyrB part of the DNA gyrase enzyme in bacteria. Its effectiveness for the treatment of Neisseria gonorrhoeae infections has...
4.
Muftah H, Ozcelik B, Oyardi O, Deliorman Orhan D
New Microbiol
. 2024 Jan;
46(4):361-366.
PMID: 38252047
The in vitro antimicrobial activity of the active ingredient in antimicrobial magistral drug formulations and plant extracts used in folk medicine were investigated comparatively. Borax, sulfur colloid, hydrogen peroxide, benzoic...
5.
Hacioglu M, Nur Yilmaz F, Oyardi O, Bozkurt Guzel C, Inan N, Savage P, et al.
Pharmaceuticals (Basel)
. 2023 Dec;
16(12).
PMID: 38139770
Ceragenins (CSAs) are a new class of antimicrobial agents designed to mimic the activities of endogenous antimicrobial peptides. In this study, the antibacterial activities of various ceragenins (CSA-13, CSA-44, CSA-90,...
6.
Oyardi O, Demir E, Alkan B, Komec S, Genc G, Aygun G, et al.
J Fungi (Basel)
. 2023 Oct;
9(10).
PMID: 37888282
has emerged as a significant fungal threat due to its rapid worldwide spread since its first appearance, along with its potential for antimicrobial resistance and virulence properties. This study was...
7.
Oyardi O, Eltimur T, Demir E, Alkan B, Savage P, Akcali A, et al.
Curr Microbiol
. 2023 May;
80(6):210.
PMID: 37191731
Myroides spp. are rare opportunistic pathogens, but they can be life-threatening because of their multidrug-resistant drug properties and their potential to cause outbreaks, especially in immunosuppressed patients. In this study,...
8.
Oyardi O, Savage P, Bozkurt Guzel C
Pathogens
. 2022 Sep;
11(9).
PMID: 36145476
is an important pathogen that can adhere to host tissues and epithelial surfaces, especially during chronic infections such as cystic fibrosis (CF) lung infections. The effect of ceragenins and antimicrobial...
9.
Hacioglu M, Oyardi O, Nur Yilmaz F, Nagl M
J Fungi (Basel)
. 2022 Jul;
8(7).
PMID: 35887439
N-chlorotaurine (NCT), the N-chloro derivative of the amino acid taurine, is a long-lived oxidant produced by stimulated human leucocytes. NCT has antimicrobial activities which are generally enhanced in the presence...
10.
Demir E, Oyardi O, Savage P, Altay H, Bozkurt-Guzel C
J Antibiot (Tokyo)
. 2022 May;
75(7):403-409.
PMID: 35562592
Burkholderia cepacia complex (Bcc) species are aerobic, Gram-negative and non-fermantative bacilli. Bcc can cause clinical symptoms in patients with cystic fibrosis, ranging from asymptomatic carriage to fatal pneumonia. A pressing...